Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

Oligonucleotide-based therapeutics present manufacturers with specific processing and characterization challenges.

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

Novo Nordisk's Stephen Gough explains how pharma can address the cardiovascular risks associated with type 2 diabetes.

How can we effectively manage the treatment of type 1 diabetes?

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

Researchers are always looking for new ways to improve effectiveness of antibody therapy.

From LIMS to AI, connected technologies are becoming a strategic initiative for an increasing number of smart companies.

How can we improve medicines for the blind and visually impaired?

Researchers create micro-feeder that eases the handling of small quantities of powder.